NDC 0591-2944

pimecrolimus

Pimecrolimus

pimecrolimus is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Pimecrolimus.

Product ID0591-2944_a3f0bc92-796c-4f74-8c7a-63001b4e9e43
NDC0591-2944
Product TypeHuman Prescription Drug
Proprietary Namepimecrolimus
Generic NamePimecrolimus
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2018-12-27
Marketing CategoryANDA / ANDA
Application NumberANDA209345
Labeler NameActavis Pharma, Inc.
Substance NamePIMECROLIMUS
Active Ingredient Strength10 mg/g
Pharm ClassesCalcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0591-2944-30

30 g in 1 TUBE (0591-2944-30)
Marketing Start Date2018-12-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0591-2944-30 [00591294430]

pimecrolimus CREAM
Marketing CategoryANDA
Application NumberANDA209345
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2018-12-27

NDC 0591-2944-87 [00591294487]

pimecrolimus CREAM
Marketing CategoryANDA
Application NumberANDA209345
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2018-12-27

NDC 0591-2944-60 [00591294460]

pimecrolimus CREAM
Marketing CategoryANDA
Application NumberANDA209345
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2018-12-27

Drug Details

Active Ingredients

IngredientStrength
PIMECROLIMUS10 mg/g

OpenFDA Data

SPL SET ID:d5b0403a-065f-42e3-96d6-7dcb9ab127d3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 562806
  • Pharmacological Class

    • Calcineurin Inhibitor Immunosuppressant [EPC]
    • Calcineurin Inhibitors [MoA]
    • Calcineurin Inhibitor Immunosuppressant [EPC]
    • Calcineurin Inhibitors [MoA]

    NDC Crossover Matching brand name "pimecrolimus" or generic name "Pimecrolimus"

    NDCBrand NameGeneric Name
    0591-2944pimecrolimuspimecrolimus
    68462-609PimecrolimusPimecrolimus
    68682-110PimecrolimusPimecrolimus
    68682-111PimecrolimusPimecrolimus
    68682-112PimecrolimusPimecrolimus
    70518-2292pimecrolimuspimecrolimus
    0187-5100ELIDELPimecrolimus
    0187-5101ELIDELPimecrolimus
    0187-5102ELIDELPimecrolimus
    0187-5103ELIDELPimecrolimus

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.